RPS18P6

Across TCGA pan-cancer cohorts, RPS18P6 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPS18P6 data layer compared with 2 for mutation status.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS18P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS18P6 expression acts as an unfavorable survival marker, although some lineages such as UVM and MESO show a favorable association.

ACC, LIHC, and OV are the cancer types where RPS18P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.342	0.732	<.001	78	view →
LIHC	OS	Quartile	All	0.670	0.805	.001	45	view →
OV	OS	Tertile	III,IV	0.236	0.374	.016	36	view →
KICH	DFS	Tertile	All	0.586	0.912	.017	30	view →
THYM	DFS	Tertile	III,IV	0.396	0.907	.003	27	view →
BLCA	OS	Tertile	IV	0.377	0.641	.028	18	view →
UVM	OS	Tertile	III,IV	1.000	0.696	.009	17	view →
PAAD	DFS	Tertile	III,IV	0.275	0.794	.008	15	view →
MESO	DFS	Quartile	All	0.765	0.283	.030	12	view →
SKCM	OS	Tertile	All	0.550	0.282	.004	10	view →
DLBC	DFS	Quartile	III,IV	0.070	0.833	.014	9	view →
KIRC	DFS	Quartile	All	0.475	0.682	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPS18P6–ACC (DFS)

Open the ACC breakdown →